BeOne Medicines (ONC) Change in Cash (2015 - 2026)
BeOne Medicines (ONC) reported Change in Cash of $243.8 million for Q1 2026, up 325.39% year-over-year from $57.3 million in Q1 2025, and down 51.16% on a QoQ basis from $499.1 million in Q4 2025.
BeOne Medicines (ONC) has 12 years of Change in Cash data on file, last reported at $243.8 million in Q1 2026.
- Quarterly Change in Cash rose 325.39% year-over-year to $243.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 939.04% YoY) and the FY2025 annual result came in at $2.0 billion, up 460.15% from the prior year.
- Change in Cash slipped to $243.8 million in Q1 2026 per ONC's latest filing, from $499.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $1.3 billion in Q3 2025 and bottomed at -$378.5 million in Q1 2024.
- The 5-year median for Change in Cash is -$74.7 million (2024), against an average of $27.7 million.
- The widest annual swing landed in 2023, when Change in Cash sank 1064.93%; it then jumped 1286.91% in 2025.
- Tracing ONC's Change in Cash over 5 years: stood at -$325.5 million in 2022, then jumped by 132.29% to $105.1 million in 2023, then slumped by 171.06% to -$74.7 million in 2024, then soared by 768.32% to $499.1 million in 2025, then sank by 51.16% to $243.8 million in 2026.
- Per Business Quant, the three latest ONC Change in Cash figures stand at $243.8 million (Q1 2026), $499.1 million (Q4 2025), and $1.3 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -153.10 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 53.61 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 243.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243.78 Mn |
| Dec 31, 2025 | 499.11 Mn |
| Sep 30, 2025 | 1.32 Bn |
| Jun 30, 2025 | 255.50 Mn |
| Mar 31, 2025 | -108.16 Mn |
| Dec 31, 2024 | -74.68 Mn |
| Sep 30, 2024 | 95.50 Mn |
| Jun 30, 2024 | -189.51 Mn |
| Mar 31, 2024 | -378.55 Mn |
| Dec 31, 2023 | 105.09 Mn |
| Sep 30, 2023 | -340.68 Mn |
| Jun 30, 2023 | -122.19 Mn |
| Mar 31, 2023 | -331.27 Mn |
| Dec 31, 2022 | -325.48 Mn |
| Sep 30, 2022 | -334.90 Mn |
| Jun 30, 2022 | 180.96 Mn |
| Mar 31, 2022 | -28.44 Mn |
| Dec 31, 2021 | 3.38 Bn |
| Sep 30, 2021 | -396.99 Mn |
| Jun 30, 2021 | -123.72 Mn |
| Mar 31, 2021 | 520.40 Mn |
| Dec 31, 2020 | -79.71 Mn |
| Sep 30, 2020 | 119.82 Mn |
| Jun 30, 2020 | -609.92 Mn |
| Mar 31, 2020 | 1.34 Bn |
| Dec 31, 2019 | -280.05 Mn |
| Sep 30, 2019 | -41.85 Mn |
| Jun 30, 2019 | 154.29 Mn |
| Mar 31, 2019 | 47.67 Mn |
| Dec 31, 2018 | 29.92 Mn |
| Sep 30, 2018 | 240.79 Mn |
| Jun 30, 2018 | -38.08 Mn |
| Mar 31, 2018 | 268.49 Mn |
| Dec 31, 2017 | 31.09 Mn |
| Sep 30, 2017 | -52.50 Mn |
| Jun 30, 2017 | 163.26 Mn |
| Mar 31, 2017 | 10.24 Mn |
| Dec 31, 2016 | 1.98 Mn |
| Sep 30, 2016 | 27.45 Mn |
| Jun 30, 2016 | -150.42 Mn |
| Mar 31, 2016 | 190.64 Mn |
| Dec 31, 2015 | -9.58 Mn |
| Sep 30, 2015 | 2.29 Mn |
| Jun 30, 2015 | 11.79 Mn |
| Mar 31, 2015 | -531,000.00 |